{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:45:01Z","timestamp":1790952301566,"version":"4.1.0"},"reference-count":28,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/eqgn8207","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:22:23Z","timestamp":1743398543000},"page":"2250-2257","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic value of NLR, PLR and SIRI in peritoneal dialysis-associated peritonitis"],"prefix":"10.62347","volume":"17","author":[{"given":"Ye","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"EMPA-KIDNEY Collaborative Group","year":"2023","unstructured":"The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C and Haynes R. Empagliflozin in patients with chronic kidney disease. N Engl J Med 2023; 388: 117-127.","journal-title":"N Engl J Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","article-title":"Prevalence and disease burden of chronic kidney disease","volume":"1165","author":"JC","year":"2019","unstructured":"Lv JC and Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol 2019; 1165: 3-15.","journal-title":"Adv Exp Med Biol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(17)30063-6","article-title":"Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of endstage renal disease across Europe: an ESPN-ERA\/EDTA registry analysis","volume":"389","author":"NC","year":"2017","unstructured":"Chesnaye NC, Schaefer F, Bonthuis M, Holman R, Baiko S, Baskın E, Bjerre A, Cloarec S, Cornelissen EAM, Espinosa L, Heaf J, Stone R, Shtiza D, Zagozdzon I, Harambat J, Jager KJ, Groothoff JW and van Stralen KJ; ESPN\/ERA-EDTA Registry Committee. Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of endstage renal disease across Europe: an ESPN-ERA\/EDTA registry analysis. Lancet 2017; 389: 2128-2137.","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Perl J, Harel Z and Nessim SJ. Peritoneal fluid analysis in peritoneal dialysis-associated peritonitis. JAMA 2022; [Epub ahead of print].","DOI":"10.1001\/jama.2022.21289"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2215\/CJN.14631218","article-title":"Peritoneal dialysis-associated peritonitis","volume":"14","author":"Szeto","year":"2019","unstructured":"Szeto CC and Li PK. Peritoneal dialysis-associated peritonitis. Clin J Am Soc Nephrol 2019; 14: 1100-1105.","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2215\/CJN.11280919","article-title":"Optimizing peritoneal dialysis-associated peritonitis prevention in the United States: from standardized peritoneal dialysis-associated peritonitis reporting and beyond","volume":"16","author":"Perl","year":"2020","unstructured":"Perl J, Fuller DS, Boudville N, Kliger AS, Schaubel DE, Teitelbaum I, Warady BA, Neu AM, Patel PR, Piraino B, Schreiber M and Pisoni RL. Optimizing peritoneal dialysis-associated peritonitis prevention in the United States: from standardized peritoneal dialysis-associated peritonitis reporting and beyond. Clin J Am Soc Nephrol 2020; 16: 154-161.","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJMicm1716367","article-title":"Uremic frost in end-stage renal disease","volume":"379","author":"Martins","year":"2018","unstructured":"Martins JM and Magriço R. Uremic frost in end-stage renal disease. N Engl J Med 2018; 379: 669.","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3931043","DOI":"10.1155\/2023\/3931043","article-title":"From diabetic nephropathy to end-stage renal disease: the effect of chemokines on the immune system","volume":"2023","author":"Qiu","year":"2023","unstructured":"Qiu Y, Tang J, Zhao Q, Jiang Y, Liu YN and Liu WJ. From diabetic nephropathy to end-stage renal disease: the effect of chemokines on the immune system. J Diabetes Res 2023; 2023: 3931043.","journal-title":"J Diabetes Res"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Qian B, Zheng Y, Jia H, Zheng X, Gao R and Li W. Neutrophil-lymphocyte ratio as a predictive marker for postoperative infectious complications: a systematic review and meta-analysis. Heliyon 2023; 9: e15586.","DOI":"10.1016\/j.heliyon.2023.e15586"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3109\/09537104.2014.979340","article-title":"The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events","volume":"26","author":"Balta","year":"2015","unstructured":"Balta S and Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets 2015; 26: 680-681.","journal-title":"Platelets"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40001-022-00733-9","article-title":"Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke","volume":"27","author":"Lin","year":"2022","unstructured":"Lin KB, Fan FH, Cai MQ, Yu Y, Fu CL, Ding LY, Sun YD, Sun JW, Shi YW, Dong ZF, Yuan MJ, Li S, Wang YP, Chen KK, Zhu JN, Guo XW, Zhang X, Zhao YW, Li JB and Huang D. Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke. Eur J Med Res 2022; 27: 106.","journal-title":"Eur J Med Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1115031","DOI":"10.3389\/fimmu.2023.1115031","article-title":"The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage","volume":"14","author":"Wang","year":"2023","unstructured":"Wang RH, Wen WX, Jiang ZP, Du ZP, Ma ZH, Lu AL, Li HP, Yuan F, Wu SB, Guo JW, Cai YF, Huang Y, Wang LX and Lu HJ. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front Immunol 2023; 14: 1115031.","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s11255-017-1632-9","article-title":"Peritoneal dialysis-related infections recommendations: 2016 update","volume":"49","author":"Liakopoulos","year":"2017","unstructured":"Liakopoulos V, Nikitidou O, Kalathas T, Roumeliotis S, Salmas M and Eleftheriadis T. Peritoneal dialysis-related infections recommendations: 2016 update. What is new? Int Urol Nephrol 2017; 49: 2177-2184.","journal-title":"What is new? Int Urol Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12882-021-02297-y","article-title":"Peritoneal dialysis-associated peritonitis caused by Mycobacteroides massiliense: the first case and review of the literature","volume":"22","author":"Hamada","year":"2021","unstructured":"Hamada S, Takata T, Kitaura T, Teraoka C, Aono A, Taniguchi S, Mae Y, Isomoto H, Chikumi H and Mitarai S. Peritoneal dialysis-associated peritonitis caused by Mycobacteroides massiliense: the first case and review of the literature. BMC Nephrol 2021; 22: 90.","journal-title":"BMC Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0002-9149(96)00878-8","article-title":"Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease","volume":"79","author":"Ommen","year":"1997","unstructured":"Ommen SR, Gibbons RJ, Hodge DO and Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol 1997; 79: 812-814.","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","unstructured":"Mehrotra R, Devuyst O, Davies SJ and Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol 2016; 27: 3238-3252.","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1132695","DOI":"10.3389\/fmed.2023.1132695","article-title":"Multidrug-resistant organism-peritoneal dialysis associated peritonitis: clinical and microbiological features and risk factors of treatment failure","volume":"10","author":"Guo","year":"2023","unstructured":"Guo S, Yang L, Zhu X, Zhang X, Meng L, Li X, Cheng S, Zhuang X, Liu S and Cui W. Multidrug-resistant organism-peritoneal dialysis associated peritonitis: clinical and microbiological features and risk factors of treatment failure. Front Med (Lausanne) 2023; 10: 1132695.","journal-title":"Front Med (Lausanne)"},{"key":"ref17","unstructured":"Ni C, Yang LM, Zhu XY, Zhang XX, Zhou WH, Xie SY, Yu MY, Zhuang XH, Luo P and Cui WP. Clinical characteristics and treatment outcome of pseudomonas peritoneal dialysis-associated peritonitis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2022; 44: 45-52."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.18097\/pbmc20206605411","article-title":"Biomarkers of system inflammation in local and diffuse peritonitis","volume":"66","author":"Mikhalchik","year":"2020","unstructured":"Mikhalchik EV, Borodina IV, Vlasova IV, Vakhrusheva TV, Gorbunov NP, Panasenko OM, Titkova SM, Anurov MV, Ivakhov GB, Ermakov IV, Teplyshev AV and Klinov DV. Biomarkers of system inflammation in local and diffuse peritonitis. Biomed Khim 2020; 66: 411-418.","journal-title":"Biomed Khim"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1744-9987.13899","article-title":"Elevation of Interleukin-6 (IL-6) in a case of icodextrin-associated peritonitis","volume":"27","author":"Alfano","year":"2023","unstructured":"Alfano G, Fontana F and Varani M. Elevation of Interleukin-6 (IL-6) in a case of icodextrin-associated peritonitis. Ther Apher Dial 2023; 27: 182-183.","journal-title":"Ther Apher Dial"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"104190","DOI":"10.1016\/j.jri.2023.104190","article-title":"The role of first trimester serum inflammatory indexes (NLR, PLR, MLR, SII, SIRI, and PIV) and the β-hCG to PAPP-A ratio in predicting preeclampsia","volume":"162","author":"Seyhanli","year":"2024","unstructured":"Seyhanli Z, Bayraktar B, Baysoz OB, Karabay G, Sucu ST, Ulusoy CO, Aktemur G, Bucak M, Cakir BT, Kurt D, Ergani SY and Iskender CT. The role of first trimester serum inflammatory indexes (NLR, PLR, MLR, SII, SIRI, and PIV) and the β-hCG to PAPP-A ratio in predicting preeclampsia. J Reprod Immunol 2024; 162: 104190.","journal-title":"J Reprod Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3390\/medicina58101502","article-title":"Inflammatory biomarkers as prognostic factors of acute deep vein thrombosis following the total knee arthroplasty","volume":"58","author":"RM","year":"2022","unstructured":"Melinte RM, Arbănaşi EM, Blesneac A, Zolog DN, Kaller R, Mureşan AV, Arbănaşi EM, Melinte IM, Niculescu R and Russu E. Inflammatory biomarkers as prognostic factors of acute deep vein thrombosis following the total knee arthroplasty. Medicina (Kaunas) 2022; 58: 1502.","journal-title":"Medicina (Kaunas)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri.2017.10","article-title":"Neutrophils as protagonists and targets in chronic inflammation","volume":"17","author":"Soehnlein","year":"2017","unstructured":"Soehnlein O, Steffens S, Hidalgo A and Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol 2017; 17: 248-261.","journal-title":"Nat Rev Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jconrel.2019.02.025","article-title":"Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation","volume":"300","author":"Saito","year":"2019","unstructured":"Saito E, Kuo R, Pearson RM, Gohel N, Cheung B, King NJC, Miller SD and Shea LD. Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation. J Control Release 2019; 300: 185-196.","journal-title":"J Control Release"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2017-06-742676","article-title":"Platelets and vascular integrity: how platelets prevent bleeding in inflammation","volume":"131","author":"Ho-Tin-No&#xE9","year":"2018","unstructured":"Ho-Tin-Noé B, Boulaftali Y and Camerer E. Platelets and vascular integrity: how platelets prevent bleeding in inflammation. Blood 2018; 131: 277-288.","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12882-023-03102-8","article-title":"Prevalence of chronic periodontitis in patients undergoing peritoneal dialysis and its correlation with peritoneal dialysis-related complications","volume":"24","author":"Chen","year":"2023","unstructured":"Chen Z, Deng H, Sun K, Huang Z, Wei S, Lin Y, Song Z and Liu Y. Prevalence of chronic periodontitis in patients undergoing peritoneal dialysis and its correlation with peritoneal dialysis-related complications. BMC Nephrol 2023; 24: 71.","journal-title":"BMC Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.3390\/ijms20153805","article-title":"Periodontal disease in patients receiving dialysis","volume":"20","author":"Miyata","year":"2019","unstructured":"Miyata Y, Obata Y, Mochizuki Y, Kitamura M, Mitsunari K, Matsuo T, Ohba K, Mukae H, Nishino T, Yoshimura A and Sakai H. Periodontal disease in patients receiving dialysis. Int J Mol Sci 2019; 20: 3805.","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12882-024-03496-z","article-title":"The association between new inflammation markers and frequent peritoneal dialysis-associated peritonitis","volume":"25","author":"Tang","year":"2024","unstructured":"Tang J, Wang D, Chen Y and Feng J. The association between new inflammation markers and frequent peritoneal dialysis-associated peritonitis. BMC Nephrol 2024; 25: 81.","journal-title":"BMC Nephrol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/3\/ajtr0159982.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:51:03Z","timestamp":1766022663000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/3\/ajtr0159982.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/eqgn8207","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}